The Latest Cardiac and Vascular News
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today the closing of its previously announced underwritten public offering of […]
New Axios IGZO-based X-ray detectors deliver an unrivaled balance of performance and value WATERLOO, Ontario, Nov. 22, 2022 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to announce its presence at the RSNA 2022 Technical Exhibition with a new offering of X-Ray detectors based on Indium Gallium Zinc Oxide (IGZO) in addition to […]
PARIS–(BUSINESS WIRE)–Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time. A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing […]
BOSTON, Nov. 21, 2022 /PRNewswire/ — Tufts Medical Center neurosurgeons Adel Malek, MD, PhD, Chief of Neurovascular Surgery, and Carl Heilman, MD, Neurosurgeon-in-Chief and Chairman of Neurosurgery, both Co-Founders of CereVasc, Inc. have been honored with the 2022 Innovation Award at the annual meeting of the Society of Vascular and Interventional Neurology (SVIN), for […]
GE Healthcare’s design for Deep Silicon detectors for a photon counting CT (PCCT) is engineered with the goal of achieving breakthroughs in both CT spatial and spectral resolution at the same time and increasing imaging performance across care areas Researchers at the University of Wisconsin–Madison will kick off research scanning […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap® technology that demonstrated potential utility in patients with adult congenital heart disease (ACHD) and refractory atrial fibrillation (AF) at the recent 15th Annual […]
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing. The retrospective trial, “Racial effects on Masimo pulse oximetry: a laboratory study,” by Drs. Steven J. Barker and Wilson C. Wilson, found that there was […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced that the resumption of commercial implants of its Aeson® artificial heart is now effective On October […]
EXCELLENT study demonstrates real-world benefits of CERENOVUS’ EMBOTRAP™ Revascularization Devices on clinical outcomes and first pass reperfusion IRVINE, Calif., Nov. 18, 2022 /PRNewswire/ — CERENOVUS, Inc., part of Johnson & Johnson MedTech*, today announced positive primary outcomes from the real-world EXCELLENT Registry focused on stroke-inducing blood clot removal by mechanical thrombectomy at the Society […]
DUBLIN, Ireland–(BUSINESS WIRE)–CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland. The procedures were performed as part of an ongoing clinical trial at the National Institute of Cardiology, […]
